TheEdgeResearch
Home / Stocks / CANC

Tema Oncology ETF (CANC)

NASDAQ Financial Services Asset Management
$43.07 ▲ +0.05%
Market Cap
$136.6M
Sector
Financial Services
Industry
Asset Management
Beta
0.70
52-Wk Range
26.1-43.38
CEO
Country
US
Currency
USD

Tema Oncology ETF operates in the Asset Management industry of the Financial Services sector, headquartered in New York, NY, US. The stock last traded at $43.07, up 0.05% on the session, giving a market capitalisation of $136.6M. Its beta of 0.70 implies it has historically moved less than the broad market.

Company profile
Exchange
NASDAQ Global Market
Employees
IPO date
2023-08-14
Headquarters
New York, NY, US
About Tema Oncology ETF

The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.

Comparable companies

Tema Oncology ETF is most often compared with the following Financial Services names:

BATTCSDCVMCKARSMAVFMINVONLNOVLHPSMDSPBC
More research on CANC
CANC technical analysis CANC TheEdge Score Compare against peers
Open full interactive analysis & DCF →